Overcoming gaps in the treatment of neurodegenerative disease

As health-care systems have adjusted to try and deal with the unprecedented scale of the COVID-19 pandemic, many routine health services were severely disrupted and gaps across social care settings have become increasingly apparent. These challenges were particularly evident when looking at the support of those with neurodegenerative diseases. An international report led by University College London (London, UK) examined the impact of COVID-19 on people with dementia and estimated mortality rates of up to 75%.